Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

Blood eosinophil counts in COPD patients compared to controls

Umme Kolsum, Thomas Southworth, Natalie Jackson, Dave Singh
European Respiratory Journal 2019 54: 1900633; DOI: 10.1183/13993003.00633-2019
Umme Kolsum
1The University of Manchester, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ukolsum@meu.org.uk
Thomas Southworth
1The University of Manchester, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK
2The Medicines Evaluation Unit, The Langley Building, Wythenshawe Hospital, Manchester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natalie Jackson
2The Medicines Evaluation Unit, The Langley Building, Wythenshawe Hospital, Manchester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dave Singh
1The University of Manchester, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK
2The Medicines Evaluation Unit, The Langley Building, Wythenshawe Hospital, Manchester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 54 no. 4
DOI 
https://doi.org/10.1183/13993003.00633-2019
PubMed 
31221811

Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Received March 29, 2019
  • Accepted June 9, 2019
  • Published online October 24, 2019.

Article Versions

  • previous version (June 20, 2019 - 00:05).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright ©ERS 2019

Author Information

  1. Umme Kolsum1⇑,
  2. Thomas Southworth1,2,
  3. Natalie Jackson2 and
  4. Dave Singh1,2
  1. 1The University of Manchester, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK
  2. 2The Medicines Evaluation Unit, The Langley Building, Wythenshawe Hospital, Manchester, UK
  1. Umme Kolsum, The University of Manchester, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK. E-mail: ukolsum{at}meu.org.uk
View Full Text

Article usage

Article usage: June 2019 to December 2020

AbstractFullPdf
Jun 20196056356
Jul 20193783041
Aug 20191981713
Sep 20191471212
Oct 20196097350
Nov 2019613156108
Dec 20194703011
Jan 202048298
Feb 20201431614
Mar 20205076
Apr 20205556
May 20203624
Jun 20203713
Jul 20202131
Aug 20203811
Sep 20204227
Oct 202060137
Nov 20204497
Dec 20203233

Altmetrics

PreviousNext
Back to top
View this article with LENS
Vol 54 Issue 4 Table of Contents
European Respiratory Journal: 54 (4)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Blood eosinophil counts in COPD patients compared to controls
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Blood eosinophil counts in COPD patients compared to controls
Umme Kolsum, Thomas Southworth, Natalie Jackson, Dave Singh
European Respiratory Journal Oct 2019, 54 (4) 1900633; DOI: 10.1183/13993003.00633-2019

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Blood eosinophil counts in COPD patients compared to controls
Umme Kolsum, Thomas Southworth, Natalie Jackson, Dave Singh
European Respiratory Journal Oct 2019, 54 (4) 1900633; DOI: 10.1183/13993003.00633-2019
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Shareable PDF
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Agora

  • Non-animal models for COVID-19 lung research
  • User-life of ICS/LABA inhaler devices should be considered
  • Genetically proxied IL-6 receptor inhibition in COVID-19 and pneumonia
Show more Agora

Research letters

  • Genetically proxied IL-6 receptor inhibition in COVID-19 and pneumonia
  • Omalizumab restores ability of human pDCs to induce Foxp3+Tregs
  • Effect of newly prescribed ICS on COPD and pneumonia hospitalisations
Show more Research letters

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2021 by the European Respiratory Society